Bank of America Downgrades Quest Diagnostics To Underperform

Analysts at Bank of America downgraded Quest Diagnostics Inc. DGX from Neutral to Underperform. Quest Diagnostics shares have gained 33.38% over the past 52 weeks, while the S&P 500 index has surged 14.22% in the same period. Quest Diagnostics' shares surged 0.45% to close at $71.77 on Friday